Octopus Biosafety Past Earnings Performance
Past criteria checks 0/6
Octopus Biosafety has been growing earnings at an average annual rate of 20.6%, while the Machinery industry saw earnings growing at 15.4% annually. Revenues have been declining at an average rate of 48.3% per year.
Key information
20.6%
Earnings growth rate
20.6%
EPS growth rate
| Machinery Industry Growth | 10.7% |
| Revenue growth rate | -48.3% |
| Return on equity | n/a |
| Net Margin | -289.3% |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Octopus Biosafety makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 0 | -1 | 0 | 0 |
| 31 Dec 21 | 1 | -1 | 1 | 0 |
| 31 Dec 20 | 1 | -1 | 1 | 0 |
| 31 Dec 19 | 0 | -1 | 1 | 0 |
| 31 Jul 17 | 1 | 0 | 0 | 0 |
| 30 Jun 16 | 0 | 0 | 0 | 0 |
| 30 Jun 15 | 0 | 0 | 0 | 0 |
| 30 Jun 14 | 0 | 0 | 0 | 0 |
Quality Earnings: OCR is currently unprofitable.
Growing Profit Margin: OCR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if OCR's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare OCR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: OCR is unprofitable, making it difficult to compare its past year earnings growth to the Machinery industry (1.8%).
Return on Equity
High ROE: OCR's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.